Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Agenus Inc (NQ: AGEN )

12.01 -0.94 (-7.26%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 7, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,268,506
Open 12.45
Bid (Size) 11.94 (1)
Ask (Size) 12.25 (1)
Prev. Close 12.95
Today's Range 10.70 - 13.00
52wk Range 0.4100 - 14.24
Shares Outstanding 348,875,959
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Agenus (AGEN) Q1 2024 Earnings Call Transcript
AGEN earnings call for the period ending March 31, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
AGEN Stock Earnings: Agenus Misses EPS, Misses Revenue for Q1 2024
AGEN stock results show that Agenus missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace

Performance

YTD
+1400.87%
+1400.87%
1 Month
+2480.02%
+2480.02%
3 Month
+1799.41%
+1799.41%
6 Month
+1436.59%
+1436.59%
1 Year
+655.35%
+655.35%

More News

Read More
Agenus Reports First Quarter 2024 Results
From Agenus Inc.
Via Business Wire
Ligand and Agenus Enter Into $100 Million Royalty Financing Agreement
From Ligand Pharmaceuticals Incorporated
Via Business Wire
Up 40%: Is This Red-Hot Growth Stock Still a Buy?
Via The Motley Fool
Agenus Regains Compliance with Nasdaq Minimum Bid Price Requirement
From Agenus Inc.
Via Business Wire
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Botensilimab/Balstilimab Data in MSS CRC Selected for the American Society of Clinical Oncology 2024 Annual Meeting
From Agenus Inc.
Via Business Wire
Top 2 Health Care Stocks Which Could Rescue Your Portfolio This Month
Via Benzinga
Agenus to Provide First Quarter 2024 Financial Report and Corporate Update
From Agenus Inc.
Via Business Wire
Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Small-Cap Cancer Drug Developer Agenus' Highlights Encouraging Data From Colorectal Cancer, But Funding Concerns Loom
Via Benzinga
Agenus Announces Updated Phase 1 Data and Progress on BOT/BAL Development in Metastatic MSS Colorectal Cancer
From Agenus Inc.
Via Business Wire
Gold Moves Higher; Auddia Shares Surge
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Crude Oil Moves Lower; Perion Network Shares Tumble
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Why Agenus Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Down 75%. Is Agenus Stock a Buy on the Dip?
Via The Motley Fool
RADCOM, Lotus Technology And 3 Stocks To Watch Heading Into Monday
Via Benzinga
Agenus Announces Reverse Stock Split of Common Stock
From Agenus Inc.
Via Business Wire
2 Stocks That Could More Than Double Your Money, According to Wall Street: Are They Buys Now?
Via The Motley Fool
3 Mind-Blowing Stocks That Could Turn $1,000 Into $1 Million
Via InvestorPlace
Agenus (AGEN) Q4 2023 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Agenus Reports Fourth Quarter and Full Year 2023 Results
From Agenus Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.